The challenge of predicting macular degeneration

Current Medical Research and Opinion

Volumn 27, Issue 9, 2011, Pages 1745-1748

  Feigl, Beatrix ^a   Morris, C Phillip ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMORPHISM; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PREDICTION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SENSITIVITY ANALYSIS; VISION TEST;

BIOLOGICAL MARKERS; HUMANS; MACULAR DEGENERATION; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PROGNOSIS; RISK FACTORS; VISION, OCULAR;

EID: 80051778424     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.603301     Document Type: Review

References (28)

1. Chakravarthy U, Evans J, Rosenfeld PJ. Age related macular degeneration. BMJ 2010;340:c981
2. Access Economics. The global economic cost of visual impairment. 2010. Available at: http://www.amdalliance.org/user-files/documents/Global% 20cost%20of%20VI-FINAL%20report.pdf [Last accessed 14 February 2011]
3. Tong Y, Liao J, Zhang Y, et al. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: a HuGE review and metaanalysis. Mol Vis 2010;16:1958-1981
4. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. PNAS 2005;102:7227-7232 (Pubitemid 40696361)
5. Schaumberg DA, Hankinson SE, Guo Q, et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007;125:55-62 (Pubitemid 46072376)
6. Chen Y, Zeng J, Zhao C, et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol 2011;129:344-351
7. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007;297:1793-800 (Pubitemid 46658648)
8. Welsh MJ, Ramsey BW, Accurso F, et al. The metabolic and molecular bases of inherited diseases. Cystic fibrosis. In: Scriver C, Volgestein B, Beaudet AL, Sly WS, Valle D (eds.) New York: McGraw-Hill, 2001:5121-5188
9. Kraft P, Hunter DJ. Genetic risk prediction-are we there yet? N Engl J Med 2009;360:1701-1703
10. Hughes AE, Orr N, Patterson C, et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. Invest Ophthalmol Vis Sci 2011;52:4694-702
11. Janssens AC, van Duijn CM. Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet 2008;17:R166-173
12. Curcio CA. Photoreceptor topography in aging and age-related maculopathy. Eye 2001;15:376-383 (Pubitemid 32605667)
13. Guymer R, Luthert P, Bird AC. Changes in Bruch's membrane and related structures with age. Prog Ret Eye Res 1999;18:59-90 (Pubitemid 28457039)
14. Feigl B. Age-related maculopathy: linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Ret Eye Res 2009;28:63-86
15. Wooten BR, Hammond Jr BR, Land RI, et al. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999;40:2481-2489 (Pubitemid 29455474)
16. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272:1413-1420 (Pubitemid 24328383)
17. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 2007;125:1225-1232 (Pubitemid 47403030)
18. Dietzel M, Zeimer M, Heimes B, et al. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the muenster aging and retina study (Mars). Invest Ophthalmol Vis Sci 2011; 52:3452-3457
19. Beatty S, van Kuijk FJ, Chakravarthy U. Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 2008;49:843-845
20. Hogg RE, Dimitrov PN, Dirani M, et al. Gene-environment interactions and aging visual function: a classical twin study. Ophthalmology 2009;116:263-269
21. Owsley C, Jackson GR, White M, et al. Delays in rod-mediated darkadaptation in early age-related maculopathy. Ophthalmology 2001;108: 1196-202 (Pubitemid 32568127)
22. Dimitrov PN, Guymer RH, Zele AJ, et al. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci 2008;49:55-65
23. Phipps JA, Dang TM, Vingrys AJ, et al. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci 2004;45:3355-3360 (Pubitemid 39121876)
24. Feigl B, Cao D, Morris CP, Zele AJ. Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision. Invest Ophthalmol Vis Sci 2011;52:1145-1150
25. Grunwald JE, Hariprasad SM, DuPont J, et al. Foveal choroidal blood flow in age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 1998; 39:385-390 (Pubitemid 28093877)
26. Chen JC, Fitzke FW, Pauleikhoff D, et al. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 1992;33:334-340
27. Stefansson E, Geirsdottir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011;30:72-80
28. Kloeckener-Gruissem B, Barthelmes D, Labs S, et al. Genetic association with response to intravitreal ranibizumab (Lucentis) in neovascular AMD patients. Invest Ophthalmol Vis Sci 2011;52:4694-702